Table 2 Immunohistochemical findings of mesonephric and mesonephric-like carcinomas.

From: Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases

Site of origin

Case ID

Tumor histology

Histologic component

PAX8

CK7

GATA3

TTF-1

ER

PR

Calretinin

CD10

WT1

p53

MMR

HNF1b

CK20

Mesonephric cervix

CX8

Mesonephric

 

P

P

  

N

N

P

P

N

WT

 

N

 

CX17

Mesonephric

              

CX26

Mixed mesonephric and endometrioid

Mesonephric

  

N

N

N

N

 

P

  

R

  

Endometrioid

  

N

N

P

P

       

CX33

Mesonephric

 

P

   

N

N

P

N

 

WT

   

CX44

Mesonephric

  

N

 

N

N

N

P

      

CX58

Mesonephric carcinosarcoma

 

P

 

P

N

N

 

P

P

 

WT

R

  

CX62

Mesonephric

 

P

P

P

N

N

N

N

P

N

WT

 

N

 

CX67

Mesonephric

     

N

N

    

R

  

Mesonephric-like ovary

OV2

Mixed mesonephric-like and serous borderline tumor

Mesonephric

P

 

P

P

N

N

N

 

N

WT

R

 

N

Serous

        

P

WT

   

OV19

Mixed mesonephric-like and low-grade serous carcinoma

Mesonephric

P

 

P

N

N

 

N

N

N

  

N

 

Serous

P

   

P

   

P

    

OV21

Mixed mesonephric-like and mucinous borderline tumor

Mesonephric

P

P

P

P

N

N

N

P

N

  

P

N

Mucinous

P

P

N

N

        

P

OV34

Mesonephric-like

 

P

 

P

P

N

N

  

N

WT

R

  

OV50

Mesonephric-like

 

P

P

P

P

N

N

N

P

N

WT

R

P

 

OV57

Mesonephric-like

 

P

 

P

P

N

     

R

  

OV66

Mesonephric-like

 

P

P

P

P

N

N

N

N

N

WT

R

P

N

OV70

Mesonephric-like

    

P

N

        

OV73

Mesonephric-like

 

P

P

P

P

F

N

N

N

N

 

R

 

N

OV74

Mixed mesonephric-like and serous borderline tumor/low-grade serous carcinoma

Mesonephric

P

P

N

P

N

N

P

 

N

  

P

 

Serous

P

P

N

N

P

P

N

 

P

  

P

 

OV75

Mixed mesonephric-like and mucinous borderline tumor

Mesonephric

P

P

P

P

F

N

  

N

WT

R

 

N

Mucinous

P

P

P

P

N

N

  

N

WT

R

 

P

OV77

Mesonephric-like

 

P

  

N

N

N

  

N

WT

R

  

OV79

Mesonephric-like carcinosarcoma

 

P

N

 

N

N

       

N

OV80

Mesonephric-like

 

P

P

P

P

N

N

P

 

N

  

N

 

OV81

Mesonephric-like

 

P

 

P

N

N

N

  

N

WT

   

Mesonephric-like endometrium

EM1

Mesonephric-like

 

P

 

N

F

N

N

       

EM36

Mesonephric-like

    

P

N

N

N

N

N

    

EM52

Mesonephric-like

 

P

P

P

N

N

N

 

P

 

WT

R

N

N

EM59

Mesonephric-like

 

P

 

P

P

N

N

N

P

  

R

  

EM61

Mesonephric-like

 

P

  

N

N

N

N

 

N

 

R

N

 

EM63

Mesonephric-like carcinosarcoma

     

N

     

R

  

EM64

Mesonephric-like

   

P

N

N

N

   

WT

R

  

EM65

Mesonephric-like carcinosarcoma

     

N

     

R

  

EM68

Mesonephric-like

 

P

P

 

P

N

N

N

  

WT

  

N

EM69

Mesonephric-like

   

P

P

N

N

N

  

WT

R

N

 

EM71

Mesonephric-like

 

P

P

 

N

N

N

   

WT

R

 

N

EM72

Mesonephric-like

 

P

 

P

 

N

N

  

N

 

R

N

 

EM76

Mesonephric-like

 

P

P

  

F

 

N

  

WT

R

  
  1. ER estrogen receptor, F focal, MMR DNA mismatch repair proteins, N negative, P positive, PR progesterone receptor, R retained, WT wild-type, Blank not performed.